Herpes B virus - Revision history

Rossdonaldson1: /* Background */

2023-07-12T21:13:54Z

Background

← Older revision		Revision as of 21:13, 12 July 2023
Line 5:		Line 5:
	*Most common transmission by bite, but very few cases		*Most common transmission by bite, but very few cases
	*Consider in Patients with Exposure, especial penetrating bites, to Macaque Monkeys in the wild or research		*Consider in Patients with Exposure, especial penetrating bites, to Macaque Monkeys in the wild or research

			{{Herpes viruses}}

	==Clinical Features<ref name="BVirus Group">[http://cid.oxfordjournals.org/content/35/10/1191.long Cohen JI, Davenport DS, Stewart JA, Deitchman S, Hilliard JK, Chapman LE; B Virus Working Group. Recommendations for prevention of and therapy for exposure to B virus (cercopithecine herpesvirus 1). Clin Infect Dis. 2002 Nov 15;35(10):1191-203. Epub 2002 Oct 17.]</ref>==		==Clinical Features<ref name="BVirus Group">[http://cid.oxfordjournals.org/content/35/10/1191.long Cohen JI, Davenport DS, Stewart JA, Deitchman S, Hilliard JK, Chapman LE; B Virus Working Group. Recommendations for prevention of and therapy for exposure to B virus (cercopithecine herpesvirus 1). Clin Infect Dis. 2002 Nov 15;35(10):1191-203. Epub 2002 Oct 17.]</ref>==

Frankj1978: spelling correction

2016-10-17T23:42:33Z

spelling correction

← Older revision		Revision as of 23:42, 17 October 2016
Line 2:		Line 2:
	*Cercopithecine herpesvirus 1 (commonly referred to as B virus)		*Cercopithecine herpesvirus 1 (commonly referred to as B virus)
	*Zoonotic Endemic in Macaque Monkeys-mild symptoms like blisters		*Zoonotic Endemic in Macaque Monkeys-mild symptoms like blisters
	*Fatal Encephalomyelitis in Humans: 80% ~~fetal~~ without treatment		*Fatal Encephalomyelitis in Humans: 80% fatal without treatment
	*Most common transmission by bite, but very few cases		*Most common transmission by bite, but very few cases
	*Consider in Patients with Exposure, especial penetrating bites, to Macaque Monkeys in the wild or research		*Consider in Patients with Exposure, especial penetrating bites, to Macaque Monkeys in the wild or research

Neil.m.young: Text replacement - "==Diagnostic Evaluation==" to "==Evaluation=="

2016-07-28T01:59:27Z

Text replacement - "==Diagnostic Evaluation==" to "==Evaluation=="

← Older revision		Revision as of 01:59, 28 July 2016
Line 20:		Line 20:
	*[[Herpes simplex virus]]		*[[Herpes simplex virus]]

	==~~Diagnostic~~ Evaluation==		==Evaluation==
	*Clinical		*Clinical
	*PCR specificity and sensitivity at nearly 100% for serologic		*PCR specificity and sensitivity at nearly 100% for serologic

Neil.m.young: Text replacement - "5 mg" to "5mg"

2016-07-19T21:34:30Z

Text replacement - "5 mg" to "5mg"

← Older revision		Revision as of 21:34, 19 July 2016
Line 41:		Line 41:
	*Admit and treat		*Admit and treat
	*Antiviral		*Antiviral
	**[[Acyclovir]] IV 12.5-~~15 mg~~/kg every eight hours OR		**[[Acyclovir]] IV 12.5-15mg/kg every eight hours OR
	**[[Ganciclovir]] IV 5mg/kg every 12 hours<ref name="CDC"></ref>		**[[Ganciclovir]] IV 5mg/kg every 12 hours<ref name="CDC"></ref>

Neil.m.young: link added

2015-09-12T19:59:45Z

link added

← Older revision		Revision as of 19:59, 12 September 2015
Line 56:		Line 56:

	==External Links==		==External Links==
			[http://www.cdc.gov/herpesbvirus/ CDC: B Virus]

	==References==		==References==

Frankj1978: References changed to footnotes

2015-09-12T14:26:23Z

References changed to footnotes

← Older revision		Revision as of 14:26, 12 September 2015
Line 6:		Line 6:
	*Consider in Patients with Exposure, especial penetrating bites, to Macaque Monkeys in the wild or research		*Consider in Patients with Exposure, especial penetrating bites, to Macaque Monkeys in the wild or research

	==Clinical Features==		==Clinical Features<ref name="BVirus Group">[http://cid.oxfordjournals.org/content/35/10/1191.long Cohen JI, Davenport DS, Stewart JA, Deitchman S, Hilliard JK, Chapman LE; B Virus Working Group. Recommendations for prevention of and therapy for exposure to B virus (cercopithecine herpesvirus 1). Clin Infect Dis. 2002 Nov 15;35(10):1191-203. Epub 2002 Oct 17.]</ref>==
	*Vesicular Herpetic Lesions		*Vesicular Herpetic Lesions
	*Nonspecific Flu-like Illness		*Nonspecific Flu-like Illness
Line 31:		Line 31:
	#<20 minutes clean and irrigate		#<20 minutes clean and irrigate
	#Antiviral prophylaxis		#Antiviral prophylaxis
	#*14 day course of PO [[valacyclovir]] 1gm three times daily		#*14 day course of PO [[valacyclovir]] 1gm three times daily OR
	#*14 day course of PO [[acyclovir]] 800mg five times daily		#*14 day course of PO [[acyclovir]] 800mg five times daily<ref name="CDC">[http://www.cdc.gov/herpesbvirus/ B Virus (herpes B, monkey B virus, herpesvirus simiae, and herpesvirus B). Centers for Disease Control and Prevention Web site. http://www.cdc.gov/herpesbvirus/ Page last reviewed: July 18, 2014. Accessed April 3, 2015.]</ref>
	#*Indications		#*Indications
	#**Penetrating (especially head, neck, torso)		#**Penetrating (especially head, neck, torso)
Line 42:		Line 42:
	*Antiviral		*Antiviral
	**[[Acyclovir]] IV 12.5-15 mg/kg every eight hours OR		**[[Acyclovir]] IV 12.5-15 mg/kg every eight hours OR
	**[[Ganciclovir]] IV 5mg/kg every 12 hours		**[[Ganciclovir]] IV 5mg/kg every 12 hours<ref name="CDC"></ref>

	===All CNS Symptomatic===		===All CNS Symptomatic===
	*Admit and treat		*Admit and treat
	*[[Ganciclovir]] IV 5mg/kg every 12 hours		*[[Ganciclovir]] IV 5mg/kg every 12 hours<ref name="CDC"></ref>

	==Disposition==		==Disposition==
Line 58:		Line 58:

	==References==		==References==
	~~#[http:~~//www.cdc.gov/herpesbvirus/ B Virus (herpes B, monkey B virus, herpesvirus simiae, and herpesvirus B). Centers for Disease Control and Prevention Web site. http://www.cdc.gov/herpesbvirus/ Page last reviewed: July 18, 2014. Accessed April 3, 2015.]		<references/>
	#[http://cid.oxfordjournals.org/content/35/10/1191.long Cohen JI, Davenport DS, Stewart JA, Deitchman S, Hilliard JK, Chapman LE; B Virus Working Group. Recommendations for prevention of and therapy for exposure to B virus (cercopithecine herpesvirus 1). Clin Infect Dis. 2002 Nov 15;35(10):1191-203. Epub 2002 Oct 17.]

	~~<references/>~~

	[[Category:ID]]		[[Category:ID]]

Rossdonaldson1: /* See Also */

2015-09-12T02:12:36Z

Rossdonaldson1: /* Management */

2015-09-12T02:11:29Z

Management

← Older revision		Revision as of 02:11, 12 September 2015
Line 32:		Line 32:
	#Antiviral prophylaxis		#Antiviral prophylaxis
	#*14 day course of PO [[valacyclovir]] 1gm three times daily		#*14 day course of PO [[valacyclovir]] 1gm three times daily
	#*14 day course of PO ~~Acyclovir~~ 800mg five times daily		#*14 day course of PO [[acyclovir]] 800mg five times daily
	#*Indications		#*Indications
	#**Penetrating (especially head, neck, torso)		#**Penetrating (especially head, neck, torso)
Line 41:		Line 41:
	*Admit and treat		*Admit and treat
	*Antiviral		*Antiviral
	**Acyclovir IV 12.5-15 mg/kg every eight hours OR		**[[Acyclovir]] IV 12.5-15 mg/kg every eight hours OR
	**Ganciclovir IV 5mg/kg every 12 hours		**[[Ganciclovir]] IV 5mg/kg every 12 hours

	===All CNS Symptomatic===		===All CNS Symptomatic===

Rossdonaldson1: /* Management */

2015-09-12T02:10:51Z

Management

← Older revision		Revision as of 02:10, 12 September 2015
Line 27:		Line 27:

	==Management==		==Management==
	*~~Treatment~~		*Consider [[rabies]] prophylaxis for all
	**<20 minutes clean and irrigate		===Asymptomatic Prophylaxis (Acute Exposure)===
	*Prophylaxis:		#<20 minutes clean and irrigate
	**14 day course of PO ~~Valacyclovir~~ 1gm three times daily		#Antiviral prophylaxis
	**14 day course of PO Acyclovir 800mg five times daily		#*14 day course of PO [[valacyclovir]] 1gm three times daily
			#*14 day course of PO Acyclovir 800mg five times daily
			#*Indications
			#**Penetrating (especially head, neck, torso)
			#**Fluid on mucosa
			#**Blistering Monkey

	*All non-CNS symptomatic: Admit and treat		===All non-CNS symptomatic===
			*Admit and treat
			*Antiviral
	**Acyclovir IV 12.5-15 mg/kg every eight hours OR		**Acyclovir IV 12.5-15 mg/kg every eight hours OR
	**Ganciclovir IV 5mg/kg every 12 hours		**Ganciclovir IV 5mg/kg every 12 hours

	*All CNS Symptomatic Admit and treat		===All CNS Symptomatic===
	**ganciclovir IV 5mg/kg every 12 hours		*Admit and treat
			*[[Ganciclovir]] IV 5mg/kg every 12 hours
	*[[Rabies]] Treatment

	~~===Asymptomatic Prophylaxis===~~
	*Treat if high risk for transmission:
	**Penetrating (especially head, neck, torso)
	**Fluid on mucosa
	**Blistering Monkey

	==Disposition==		==Disposition==

Rossdonaldson1: /* Management */

2015-09-12T02:05:55Z

Management

← Older revision		Revision as of 02:05, 12 September 2015
Line 27:		Line 27:

	==Management==		==Management==
	*Asymptomatic Prophylaxis Treatment
	**Treat if high risk for transmission:
	***Penetrating (especially head, neck, torso)
	***Fluid on mucosa
	***Blistering Monkey
	***Discuss with patient
	*Treatment		*Treatment
	**<20 minutes clean and irrigate		**<20 minutes clean and irrigate
	*Prophylaxis:		*Prophylaxis:
	**14 day course of PO Valacyclovir 1gm three times daily		**14 day course of PO Valacyclovir 1gm three times daily
	((14 day course of PO Acyclovir 800mg five times daily		**14 day course of PO Acyclovir 800mg five times daily

	*All non-CNS symptomatic: Admit and treat		*All non-CNS symptomatic: Admit and treat
Line 47:		Line 41:

	*[[Rabies]] Treatment		*[[Rabies]] Treatment

			===Asymptomatic Prophylaxis===
			*Treat if high risk for transmission:
			**Penetrating (especially head, neck, torso)
			**Fluid on mucosa
			**Blistering Monkey

	==Disposition==		==Disposition==

← Older revision		Revision as of 02:12, 12 September 2015
Line 53:		Line 53:

	==See Also==		==See Also==
			*[[Mammalian bites]]

	==External Links==		==External Links==